Comparison of a Septal Stapler to Suture Closure in Nasal Septoplasty

Status Completed

Clinical Trial Summary

The primary objective of this study is to determine if there is a time savings in the operating room by using a septal stapler instead of suture in closure of primary septoplasty. The secondary objectives are to determine the subjective outcome of patients undergoing closure with the septal stapler instead of suture via questionnaire, and to determine if there is a difference in postoperative complications between groups.

Clinical Trial Description

Nasal Septoplasty is the third most common surgical procedure performed by otolaryngologists. The surgery is done to relieve nasal obstruction, which is often caused by a bend in the tissues in the middle of the nose. The current technique for completing a septoplasty involves elevating subperichondrial flaps bilaterally and resecting the deviated portion of cartilage and/or bone. The technique to prevent a septal hematoma by removing the potential dead space after cartilage resection has evolved over time. Traditionally, the nose was packed with petroleum gauze, but using sutures to coapt the mucosa back together has become the preferred method of choice. Placing sutures to reapproximate the mucosa is very effective, but can be challenging, particularly in a narrow nose. The amount of time required varies from 4 to 20 minutes for this part of the surgery, and is potentially associated with its own set of complications. The needle or suture can break, and the lateral nasal wall can be traumatized, leading to formation of scar bands to the septum. Recently, a septal stapler has been developed that uses bioabsorbable staples. The staples are made of polylactide-co-glycolide (PLG), the same copolymer found in Vicryl sutures. It can provide a more uniform closure, is able to reach the posterior septum and could lead to a significant time savings in the operating room. The stapler has been demonstrated to be safe and effective, and required less than a minute to apply in most studied cases. The amount of time saved in the operating room has not yet been studied. ;

Study Design

Related Conditions & MeSH terms

Nasal Obstruction

Clinical Trial Details

NCT number	NCT01541839
Study type	Interventional
Source	University of Alberta
Contact
Status	Completed
Phase	N/A
Start date	February 2012
Completion date	March 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05582070` - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction	N/A
Recruiting	`NCT04228016` - Efficacy of an Intranasal Stent on Nasal Obstruction at Night	N/A
Completed	`NCT02914236` - Treatment of Nasal Airway Obstruction Using the Aerin Medical Device	N/A
Completed	`NCT02952313` - Spirox Latera™ Implant Support of Lateral Nasal Wall Cartilage (LATERAL-OR) Study	N/A
Completed	`NCT01965457` - Assessment of Adenoidal Obstruction in Children : Clinical Signs Versus Flexible Nasal Endoscopy and Roentgenographic Findings	N/A
Completed	`NCT00850876` - Heated Humidified Continuous Positive Airway Pressure and Nasal Physiology	N/A
Completed	`NCT03156270` - Treatment Outcome Using Vivaer Stylus to Treat Nasal Airway Obstruction	N/A
Active, not recruiting	`NCT05099263` - The Vivaer Procedure for Treatment of the Septal Swell Bodies (SWELL)	N/A
Recruiting	`NCT05573919` - VivAer: A Correlation Between Symptom Scores and Objective Findings	N/A
Completed	`NCT03290300` - Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device
Recruiting	`NCT04499469` - The Role of Spreader Grafts in Reduction Rhinoseptoplasty: a Randomized Clinical Trial With Quality of Life Assessment	N/A
Not yet recruiting	`NCT01702103` - Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays	Phase 3
Completed	`NCT04220853` - Changes in Nasal Airflow Parameters After Septoplasty and Turbinoplasty	N/A
Completed	`NCT03456115` - A New Treatment for Mechanical Nasal Obstruction	N/A
Completed	`NCT00793117` - The Effect of Packing in Post Operative Management of FESS	Phase 4
Completed	`NCT02964312` - LATERA-OFFICE Study	N/A
Recruiting	`NCT04150783` - Computational Modeling of Cleft Lip Nasal Deformity and Assessment of Nasal Function and Treatment Outcomes
Completed	`NCT01506583` - Clinical Evaluation of QFlu Combo Test
Recruiting	`NCT03925389` - Outcome Analysis in Septorhinoplasty
Recruiting	`NCT05494346` - Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.